Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Davidson

Showing results (191-200 of 358) with videos related to

Pageof 36
Sort By:
American Journal of Clinical Pathology|September 9, 2005
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcomeAna Slipicevic, Ruth Holm, Mai T P Nguyen, et al.
American Journal of Clinical Pathology|February 18, 2005
Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusionsBen Davidson, Zhijun Xi, Tove Irene Klokk, et al.
Oncotarget|October 6, 2017
MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancerYvonne Andersson, Synne Ihler Haavardtun, Ben Davidson, et al.
Virchows Archiv : an International Journal of Pathology|November 25, 2017
The diagnostic role of PTEN and ARID1A in serous effusionsBen Davidson, Maurizio Pinamonti, Dolors Cuevas, et al.
BMC Cancer|August 5, 2016
L1CAM as a prognostic marker in stage I endometrial cancer: a validation studyElisabeth Smogeli, Ben Davidson, Milada Cvancarova, et al.
The American Journal of Pathology|July 31, 2010
Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatinJoon Tae Park, Xu Chen, Claes G Tropè, et al.
American Journal of Clinical Pathology|May 6, 2016
Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine LeiomyosarcomaBen Davidson, Marna Lill Kjæreng, Mette Førsund, et al.
Genes, Chromosomes & Cancer|April 13, 2013
Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocationIoannis Panagopoulos, Jim Thorsen, Ludmila Gorunova, et al.
Virchows Archiv : an International Journal of Pathology|December 18, 2012
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinomaHelene Tuft Stavnes, Dag André Nymoen, Anita Langerød, et al.
Human Pathology|September 26, 2006
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinomaElin Ødegaard, Anne Cathrine Staff, Vera M Abeler, et al.
Pageof 36

Showing results (191-200 of 358) with videos related to

Sort By:
Pageof 36
American Journal of Clinical Pathology|September 9, 2005
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcomeAna Slipicevic, Ruth Holm, Mai T P Nguyen, et al.
American Journal of Clinical Pathology|February 18, 2005
Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusionsBen Davidson, Zhijun Xi, Tove Irene Klokk, et al.
Oncotarget|October 6, 2017
MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancerYvonne Andersson, Synne Ihler Haavardtun, Ben Davidson, et al.
Virchows Archiv : an International Journal of Pathology|November 25, 2017
The diagnostic role of PTEN and ARID1A in serous effusionsBen Davidson, Maurizio Pinamonti, Dolors Cuevas, et al.
BMC Cancer|August 5, 2016
L1CAM as a prognostic marker in stage I endometrial cancer: a validation studyElisabeth Smogeli, Ben Davidson, Milada Cvancarova, et al.
The American Journal of Pathology|July 31, 2010
Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatinJoon Tae Park, Xu Chen, Claes G Tropè, et al.
American Journal of Clinical Pathology|May 6, 2016
Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine LeiomyosarcomaBen Davidson, Marna Lill Kjæreng, Mette Førsund, et al.
Genes, Chromosomes & Cancer|April 13, 2013
Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocationIoannis Panagopoulos, Jim Thorsen, Ludmila Gorunova, et al.
Virchows Archiv : an International Journal of Pathology|December 18, 2012
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinomaHelene Tuft Stavnes, Dag André Nymoen, Anita Langerød, et al.
Human Pathology|September 26, 2006
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinomaElin Ødegaard, Anne Cathrine Staff, Vera M Abeler, et al.
Pageof 36